Anu Kareinen

506 total citations
13 papers, 398 citations indexed

About

Anu Kareinen is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery. According to data from OpenAlex, Anu Kareinen has authored 13 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Physiology and 4 papers in Surgery. Recurrent topics in Anu Kareinen's work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Diabetes Treatment and Management (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Anu Kareinen is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Diabetes Treatment and Management (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Anu Kareinen collaborates with scholars based in Finland and United States. Anu Kareinen's co-authors include Markku Laakso, Laura Viitanen, Seppo Lehto, Ilkka Vauhkonen, Pirjo Halonen, Eric S. Lander, Mark J. Daly, Jorma Viikari, Leena Peltonen and Markus Perola and has published in prestigious journals such as Diabetes Care, Free Radical Biology and Medicine and The American Journal of Human Genetics.

In The Last Decade

Anu Kareinen

13 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anu Kareinen Finland	10	154	134	129	103	88	13	398
Laura Viitanen Finland	9	166 1.1×	135 1.0×	131 1.0×	81 0.8×	96 1.1×	12	406
S. Takami Japan	11	204 1.3×	186 1.4×	93 0.7×	146 1.4×	56 0.6×	12	513
Eric Boerwinkle United States	8	81 0.5×	175 1.3×	197 1.5×	91 0.9×	129 1.5×	10	502
Neslihan Çoban Türkiye	13	139 0.9×	98 0.7×	89 0.7×	96 0.9×	61 0.7×	37	404
Lorenzo Castello Italy	7	138 0.9×	106 0.8×	64 0.5×	215 2.1×	50 0.6×	19	504
Ka Wah Li United Kingdom	9	69 0.4×	95 0.7×	178 1.4×	121 1.2×	149 1.7×	11	511
K.-H. Usadel Germany	11	104 0.7×	195 1.5×	60 0.5×	159 1.5×	61 0.7×	31	476
Magdalena González Chile	11	142 0.9×	253 1.9×	106 0.8×	203 2.0×	70 0.8×	16	595
Toshihide Shike Japan	10	78 0.5×	90 0.7×	56 0.4×	117 1.1×	90 1.0×	15	443
P.J. Lejeune France	10	88 0.6×	89 0.7×	74 0.6×	53 0.5×	25 0.3×	12	343

Countries citing papers authored by Anu Kareinen

Since Specialization

Citations

This map shows the geographic impact of Anu Kareinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anu Kareinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anu Kareinen more than expected).

Fields of papers citing papers by Anu Kareinen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anu Kareinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anu Kareinen. The network helps show where Anu Kareinen may publish in the future.

Co-authorship network of co-authors of Anu Kareinen

This figure shows the co-authorship network connecting the top 25 collaborators of Anu Kareinen. A scholar is included among the top collaborators of Anu Kareinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anu Kareinen. Anu Kareinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Luoma, Jukka, Anu Kareinen, Outi Närvänen, et al.. (2005). Autoantibodies against oxidized LDL are associated with severe chest pain attacks in patients with coronary heart disease. Free Radical Biology and Medicine. 39(12). 1660–1665. 8 indexed citations

Pihlajamäki, Jussi, Pauli Karhapää, Ilkka Vauhkonen, et al.. (2003). The Leu7Pro polymorphism of the neuropeptide Y gene regulates free fatty acid metabolism. Metabolism. 52(5). 643–646. 14 indexed citations

Pajunen, Pia, Mikko Syvänne, Markku S. Nieminen, et al.. (2002). Serum homocysteine, creatinine, and glucose as predictors of the severity and extent of coronary artery disease in asymptomatic members of high‐risk families. European Journal of Clinical Investigation. 32(7). 472–478. 11 indexed citations

Simula, Sakari, Esko Vanninen, Laura Viitanen, et al.. (2002). Cardiac adrenergic innervation is affected in asymptomatic subjects with very early stage of coronary artery disease.. PubMed. 43(1). 1–7. 24 indexed citations

Viitanen, Laura, Jussi Pihlajamäki, Raija Miettinen, et al.. (2001). Apolipoprotein E gene promoter (–219G/T) polymorphism is associated with premature coronary heart disease. Journal of Molecular Medicine. 79(12). 732–737. 43 indexed citations

Kareinen, Anu, Laura Viitanen, Pirjo Halonen, Seppo Lehto, & Markku Laakso. (2001). Cardiovascular Risk Factors Associated With Insulin Resistance Cluster in Families With Early-Onset Coronary Heart Disease. Arteriosclerosis Thrombosis and Vascular Biology. 21(8). 1346–1352. 37 indexed citations

Pajukanta, Päivi, Michele Cargill, Laura Viitanen, et al.. (2000). Two Loci on Chromosomes 2 and X for Premature Coronary Heart Disease Identified in Early- and Late-Settlement Populations of Finland. The American Journal of Human Genetics. 67(6). 1481–1493. 130 indexed citations

Viitanen, Laura, et al.. (2000). MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.. Diabetes Care. 23(6). 791–795. 32 indexed citations

Viitanen, Laura, et al.. (2000). Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. Journal of Molecular Medicine. 78(7). 372–379. 62 indexed citations

10.

Viitanen, Laura, et al.. (2000). MSPI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of high density lipoprotein cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. Atherosclerosis. 151(1). 179–179. 1 indexed citations

11.

Viitanen, Laura, et al.. (2000). Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. Atherosclerosis. 151(1). 207–207. 3 indexed citations

12.

Kareinen, Anu, et al.. (1999). The codon 64 polymorphism of the β3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients. Metabolism. 48(7). 853–856. 18 indexed citations

13.

Kareinen, Anu, et al.. (1998). Variants of the Fatty Acid-Binding Protein 2 Gene Are Not Associated With Coronary Heart Disease in Nondiabetic Subjects and in Patients With NIDDM. Diabetes Care. 21(5). 849–850. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact